United States · Venture startup
4 rounds we have observed, with the 13 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$100Mraised across 4 rounds since 2006, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Greylock
New Leaf Venture Partners
TVM Capital
Skyline Ventures
QVT Financial LPFrom a historical funding record
GreylockNew Leaf Venture PartnersTVM CapitalSkyline VenturesQVT Financial LPReported by concertpharma.com
Reported by concertpharma.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
GreylockTVM CapitalThree Arch PartnersSkyline VenturesQVT Financial LPNew Leaf Venture PartnersFlagship Pioneering, LLCBrookside CapitalAdage Capital Management
GlaxoSmithKlineMissing a round, or an investor who was in one? Tell us.
Concert Pharmaceuticals's investors include Greylock, TVM Capital, Three Arch Partners, Skyline Ventures and QVT Financial LP, and 8 more on record.
Concert Pharmaceuticals has raised $100M across 4 rounds since 2006.
Concert Pharmaceuticals's most recent round was a Venture of $4.0M in Jun 2011.
Concert Pharmaceuticals's largest round on record is $49M (Series B), in Nov 2006.
Concert Pharmaceuticals's first round on record, in Jul 2006, was backed by Greylock, TVM Capital and Three Arch Partners and 2 others.
Concert Pharmaceuticals's latest named round is a Venture, in Jun 2011.
Concert Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·